Free
Case Report  |   January 1993
Juvenile myoclonic epilepsy
Article Information
Case Report   |   January 1993
Juvenile myoclonic epilepsy
The Journal of the American Osteopathic Association, January 1993, Vol. 93, 126. doi:10.7556/jaoa.1993.93.1.126
The Journal of the American Osteopathic Association, January 1993, Vol. 93, 126. doi:10.7556/jaoa.1993.93.1.126
Abstract

Juvenile myoclonic epilepsy is a genetically transferred generalized epilepsy that affects approximately 7% of adolescents and adults with epilepsy. Juvenile myoclonic epilepsy always has a myoclonic component alone or in combination with generalized tonic-clonic seizure or absence seizure. The myoclonic component is most prominent on waking or in a drowsy state. The electroencephalogram may be normal between seizures. Life-long treatment with valproate is effective in more than 80% of patients. The author describes the clinical features, diagnosis, and treatment of juvenile myoclonic epilepsy in a typical patient.